REQUEST A DEMO
Total
USD $0.00
Search more companies

Unite De Fabrication De Medicaments Sa (Tunisia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Unite De Fabrication De Medicaments Sa Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Unite De Fabrication De Medicaments (UNIMED) is amongst the first Tunisian pharmaceutical laboratories. It was set up by its chairman and managing director Ridha Charfeddine in 1989. Relying on its human potential and expertise which constitute its growth pillars, UNIMED has successfully helped in the development of the Tunisian pharmaceutical industry so that it attracts various foreground pharmaceutical groups as well in partnership at the level of Galen’s development as in subcontracting and pharmaceutical manufacturing. Being devoted to its strategy over time, UNIMED has extended its product range containing from now on ophta-ORL solutions, liquids for injection, penicillin powders as well as cephalosporins for injection.

Headquarters
Zone Industrielle De Kalaa Kebira
Sousse; Sousse; Postal Code: 4060

Contact Details: Purchase the Unite De Fabrication De Medicaments Sa report to view the information.

Website: http://www.unimed.com.tn

Basic Information
Total Employees:
Purchase the Unite De Fabrication De Medicaments Sa report to view the information.
Outstanding Shares:
Purchase the Unite De Fabrication De Medicaments Sa report to view the information.
Financial Auditors:
Purchase the Unite De Fabrication De Medicaments Sa report to view the information.
Incorporation Date:
1989
Key Executives
Purchase this report to view the information.
Executive Vice President
Purchase this report to view the information.
Executive Vice President
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
29.26%
Purchase this report to view the information.
17.7%
Company Performance
Financial values in the chart are available after Unite De Fabrication De Medicaments Sa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TND. Absolute financial data is included in the purchased report.
Net sales revenue
8.1%
Total operating revenue
8.27%
Operating profit (EBIT)
12.97%
EBITDA
11.79%
Net Profit (Loss) for the Period
13.3%
Total assets
2.47%
Total equity
6.76%
Operating Profit Margin (ROS)
0.86%
Net Profit Margin
0.52%
Return on Equity (ROE)
0.43%
Debt to Equity Ratio
1.07%
Quick Ratio
0.31%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?